IRA’s Orphan Drug Exemption Could Lead to More Off-Label Prescribing

 
• By Sarah Karlin-Smith
  
Zebras
Rare disease advocates believe IRA will jeopardize filing of supplemental marketing applications for orphan drugs. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet